Retatrutide 10 mg

$75.00

Retatrutide is an investigational triple-receptor agonist that engages GIP, GLP-1, and glucagon receptor pathways. It is being examined in clinical research involving metabolic regulation and body-weight outcomes but is not yet an approved therapeutic product. Supplied as a 10 mg lyophilized research vial.

For research purposes only. Not for human consumption.

 

In stock

Categories: Fat Loss

Retatrutide is a synthetic peptide designed to activate three metabolic signaling pathways: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. These pathways are widely studied for their roles in glucose homeostasis, appetite regulation, energy expenditure, and broader metabolic function.

Laboratory and clinical research involving Retatrutide has examined body-weight regulation, insulin sensitivity, glucose control, lipid-related metabolic markers, and energy-balance mechanisms. Its triple-receptor activity makes it a compound of significant interest in research focused on metabolic physiology and body-composition-related pathways.

Product Details

  • 10mg lyophilized Retatrutide
  • Research-grade material
  • Supplied in a sealed research vial
  • Independent analytical testing documentation provided when available

Research Use Only

This product is intended strictly for laboratory and research purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or administration.